In the second expansion announced this month, generic API maker Cambrex has a deal to buy a clinical supply manufacturer.

After Sarepta Therapeutics this week won FDA approval for its controversial Duchenne muscular dystrophy drug, the CEO assured analysts it has a plan to ramp up…

Moderna Therapeutics, the much-ballyhooed Cambridge-based biotech developing a cutting-edge mRNA treatment platform, says it will build a $110 million…

Sun Pharmaceutical, which has been dealing with FDA concerns over plants in India, is now recalling more than 12,000 bottles of a beta blocker made at a plant…

The FDA put a Chinese biologics drugmaker on import alert and followed up with a warning letter after an inspection a year ago that found serious microbial…

German CDMO Rentschler Biotechnologie has added a new facility to its site in Laupheim, expanding its biologics capacity for the second time in a year. The…

The EMA said Monday that it is recommending the ban in Europe of all but one of the drugs manufactured by Pharmaceutics International.

Having won a couple of deals to build its prefabricated manufacturing facilities in Asia, GE will now invest €150 million to build out an entire campus in…